HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dolan, N. C. Articles by McDermott, M. M. Search for Related Content PubMed PubMed Citation Articles by Dolan, N. C. Articles by McDermott, M. M. Social Bookmarking                What's this?

Peripheral Artery Disease, Diabetes, and Reduced Lower Extremity Functioning

¹ Department of Medicine, Northwestern University Medical School, Chicago, Illinois
² Department of Preventive Medicine, Northwestern University Medical School, Chicago, Illinois
³ Department of Family and Preventive Medicine, University of California at San Diego, San Diego, California
⁴ Epidemiology, Demography, and Biometry Program, National Institute on Aging, Bethesda, Maryland
⁵ Division of Vascular Surgery, Department of Surgery, Northwestern University Medical School, Chicago, Illinois
⁶ Division of Vascular Surgery, Department of Surgery, Evanston/Northwestern Hospital, Evanston, Illinois

	ABSTRACT

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS References

 
OBJECTIVE—To characterize lower extremity function and dysfunction in peripheral artery disease (PAD) patients with and without diabetes.

RESEARCH DESIGN AND METHODS—In this cross-sectional study, 460 men and women with PAD (147 with diabetes) were recruited from three academic medical centers. Assessments included ankle brachial index (ABI), neuropathy score, 6-min walk distance, 4-m walking velocity, Walking Impairment Questionnaire (0–100 scale, 100 = best), and summary performance score (SPS) (0–12 scale, 12 = best).

RESULTS—The mean ABI was similar in PAD patients with and without diabetes. PAD patients with diabetes were younger, had a higher BMI, had a worse neuropathy score, and had a greater number of cardiovascular comorbidities compared with those without diabetes. Participants with diabetes were less likely to report classical symptoms of intermittent claudication and more likely to report exertional leg pain, which sometimes started at rest. After adjusting for age, those with diabetes had a shorter mean 6-min walk distance (1,040 vs. 1,168 feet, P < 0.001), slower fast-pace 4-m walk velocity (0.83 vs. 0.90 m/sec, P < 0.001), and a lower SPS (7.3 vs. 8.6, P < 0.001) than those without diabetes. Patients with diet-controlled diabetes performed better than those on diabetes medications. Differences in lower extremity functioning between patients with and without diabetes were largely attenuated but not abolished for SPS and fast-pace 4-m walk velocity after adjustment for type of exertional leg pain, neuropathy score, and number of cardiovascular comorbidities.

CONCLUSIONS—Subjects with PAD and diabetes have poorer lower extremity function than those with PAD alone. This difference in functioning appears to be largely explained by diabetes-associated neuropathy, differences in exertional leg symptoms, and greater cardiovascular disease in patients with diabetes.

Abbreviations: ABI, ankle brachial index • CHS, Cardiovascular Health Study • GDS, Geriatric Depression Scale • PAD, peripheral artery disease • PCP, primary care physician • SPS, summary performance score • WHAS, Women’s Health and Aging Study • WIQ, Walking Impairment Questionnaire

	INTRODUCTION

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS References

 
Diabetes is common in men and women with peripheral artery disease (PAD). In the Framingham study (1), 20% of men and women with intermittent claudication had diabetes compared with 6% of those without intermittent claudication. Diabetes and PAD are both frequently complicated by neuropathy and foot ulceration, and each condition is associated with an increased risk of gangrene and lower extremity amputation (2,3,4).

Among individuals in the general population, diabetes has also been associated with increased disability, poorer physical functioning, and an increased risk of being unable to do mobility-related tasks (3,5,6). The excess risk of disability among people with diabetes may be related to the complications and comorbidities commonly associated with diabetes (5). Whether the excess risk of disability associated with diabetes is exacerbated in subjects with PAD has not been previously studied.

Impaired lower extremity functioning is an important predictor of future disability, mobility loss, and nursing home placement (7,8). Maintaining function is an important public health objective because it allows men and women with chronic diseases such as diabetes and PAD to live longer. Establishing whether individuals with PAD and diabetes have greater impairment in lower extremity functioning than individuals with PAD without diabetes—and, if so, why they have greater impairment—could have important clinical implications for the prevention of disability in patients with PAD. The purpose of this study was to compare lower extremity functioning between PAD patients with and without diabetes. We hypothesized that PAD patients with diabetes, regardless of PAD severity, as measured by the ankle brachial index (ABI), have poorer lower extremity functioning than those without diabetes.

	RESEARCH DESIGN AND METHODS

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS References

 
Participant identification
We defined PAD as an ABI <0.90. The study findings, therefore, are generalizable only to those PAD patients with compressible ankle vessels. Participants were identified from consecutive men and women aged 55 years with lower extremity arterial studies consistent with PAD at one of three Chicago-area medical centers’ noninvasive blood flow laboratories between 1 January 1997 and 31 October 1999. Fewer participants were identified from general medicine patients aged 55 years with ABIs <0.90 who were seen in a large practice affiliated with Northwestern University Medical School.

Identified individuals were invited to return to the medical center for a study visit. The visit consisted of a comprehensive interview, lower extremity functional measurements, and a physical examination that included ABI, BMI, and monofilament testing for neuropathy. The Institutional Review Boards of Northwestern University Medical School and Catholic Health Partners approved the study protocol, and all participants gave informed consent.

A total of 150 participants were excluded because their ABI was 0.90 at the study visit. Patients who resided in nursing homes, were wheelchair-dependent, had leg or foot amputations, did not speak English, or had Mini-Mental Status scores of <18 were also excluded from the study.

ABI measurement
Based on a previous study, ABI was calculated by averaging the dorsalis pedis and posterior tibial artery pressures in each limb and dividing this pressure by the average of the four brachial artery pressures (9). The average of the brachial artery pressures in the arm with the highest pressure was used when one brachial arterial pressure was greater than the other in both measurement sets and when the right and left brachial artery pressures differed by 10 mmHg.

Leg symptom groups
Leg symptoms were ascertained using the San Diego claudication questionnaire (10). Participants were categorized into five mutually exclusive leg pain groups: 1) no exertional leg pain; 2) atypical exertional leg pain/carry-on, defined as exertional leg symptoms that do not begin at rest and do not cause the participant to stop walking; 3) atypical exertional leg pain/stop, defined as exertional leg symptoms that do not begin at rest, are not consistent with intermittent claudication, and cause the participant to stop walking; 4) intermittent claudication, defined as exertional calf pain that does not begin at rest, causes the participant to stop walking, and resolves within 10 min of rest; and 5) leg pain with exertion and rest, defined as exertional leg pain that sometimes begins at rest.

Identifying diabetes and diabetes severity
We documented the presence of diabetes using a disease-specific algorithm from the Women’s Health and Aging Study (WHAS) and the Cardiovascular Health Study (CHS) (11). The algorithm combines data from patient report, the medical record, medications, and a primary care physician (PCP) questionnaire (11). Diabetes was considered present if at least two of the following criteria were satisfied: 1) the patient reported physician-diagnosed diabetes; 2) the patient was taking diabetes medications; 3) there was a medical record report of a GHb >10%; and 4) the PCP questionnaire reported a diagnosis of diabetes. If the first three criteria were not satisfied but the PCP questionnaire indicated diabetes, the physician was recontacted for confirmation. If the diagnosis was confirmed, the patient was considered to have diabetes. The algorithm does not distinguish between type 1 and type 2 diabetes. To estimate diabetes severity, participants with diabetes were classified according to their use of diabetes medication: 1) no diabetes medication; 2) oral medications only; or 3) insulin with or without oral medication.

Other medical conditions
Comorbidities other than diabetes that were previously shown or expected to influence lower extremity functioning were identified using methods from the WHAS and the CHS (11). These included angina, myocardial infarction, stroke, heart failure, pulmonary disease, knee and hip arthritis, spinal stenosis, disc disease, Parkinson’s disease, and hip fracture (12,13). The presence of high cholesterol was determined using medical records and PCP questionnaire, whereas hypertension was determined by self-report and PCP questionnaire. Physician-diagnosed vision problems were established by self-report.

We used the Geriatric Depression Scale (GDS) short form to ascertain the presence of depressive symptoms (range 0–15, higher = more depression) (14). Depression was defined as the presence of six or more depressive symptoms on the GDS (14). A monofilament was used to assess sensation on the dorsal and ventral surfaces of each foot in specific locations as previously described (15,16). The ordinal neuropathy score that was developed represented the number of items missed on the monofilament test (range 0–22, higher = worse).

Lower extremity functional measures
Measure of walking endurance: the 6-min walk.
The 6-min walk distance measures endurance and correlates significantly with time to onset of leg pain during treadmill testing, maximum distance achieved in treadmill testing, physical activity levels, and ABI (9,17,18). Using a standardized protocol, participants were instructed to walk up and down a 100-foot distance for 6 min, covering as much distance as possible (17,18).

Measures of walking speed: 4-m walking velocities.
The usual and fast-pace 4-m walking velocities measure the time it takes participants to walk a 4-m distance at both their usual and fastest pace, respectively. Both of these walks were performed twice, and the fastest walk in each set (usual and fastest pace) was used in analyses (8).

Measures of balance and strength: tandem stand and repeated chair rises.
The full tandem stand measures whether or not participants can stand with both feet together side-by-side for 10 s (7,8). The repeated chair rises test measures the time it takes to complete five chair rises and is a measure of leg strength as well as balance (7,8).

Measures of physical activity
Physical activity levels were measured over 7 days using the Caltrac accelerometer (19,20,21). Based on previous study, we programmed accelerometers using identical weight, height, age, and sex for each participant so that activity could be compared meaningfully among all study participants (19,20,21). Programmed in this manner, the accelerometer measures activity units. Because we had a relatively small number of accelerometers, they were distributed to participants when available. Forty-six percent of the study participants wore the accelerometer. There were no significant differences in age, sex, BMI, or diabetes prevalence between those who wore the accelerometer and those who did not. Self-reported physical activity was measured by asking all participants to estimate the number of stairs climbed and city blocks that they had walked in the past week.

Walking Impairment Questionnaire
The Walking Impairment Questionnaire (WIQ) measures self-reported walking speed and distance among PAD patients (22,23). To measure walking distance, participants ranked their ability to walk specific distances on a 0–4 Likert scale. The WIQ distance score was calculated by multiplying the Likert scale score with the corresponding distance, summing these products, and then dividing by the maximum score possible to get a percent score that ranged from 0 to 100 (100 = best). Walking speed was assessed by asking subjects to rank their degree of difficulty walking a block slowly, at average speed, quickly, or running/jogging on a 0–4 Likert scale (4 = best). Participants’ responses on the Likert scale were multiplied by the approximate miles per hour represented by each walking speed. The resultant score was divided by the maximum possible score to achieve a percent score that ranged from 0 to 100 (100 = best).

Composite measure of lower extremity functioning: summary performance score
The summary performance score (SPS) measures leg strength, balance, and usual walking speed (8). To calculate the SPS, a 0–4 score was assigned for 4-m walking velocity, chair rises, and standing balance, respectively, based on cut points derived from normative data of representative community populations. These scores were summed to obtain the SPS, which ranged from 0 to 12 (12 = best) (9,24).

Statistical analyses
Differences in clinical characteristics and lower extremity functional measures between PAD participants with and without diabetes were assessed using analysis of covariance while adjusting for age. Statistical significance was based on logistic regression for dichotomous variables and analysis of variance for continuous variables. Using a forward-selection method, multiple linear models were developed to test for potential predictors that accounted for differences between participants with and without diabetes in the following lower extremity functional measures: 6-min walk distance, fastest pace 4-m walking velocity, WIQ speed performance score, and SPS. These four measures were chosen based on their strong correlation with ABI (19,25). First, potential confounders, including age, sex, race (African-American or non–African-American), and BMI, were simultaneously forced into the first model on the basis of previous studies. Second, other potential predictors, including four dummy variables for leg symptoms (exertional leg pain/carry-on, exertional leg pain/stop, intermittent claudication, and leg pain with exertion and rest, with no exertional leg pain used as the reference category), neuropathy score, number of cardiovascular diseases (including myocardial infarction, heart failure, angina, and stroke), number of arthritis diseases (including knee and hip arthritis, hip fracture, spinal stenosis, and disc disease), number of other diseases (pulmonary disease and cancer), depression score, and ABI were entered one at a time into the linear model. From these analyses, we selected as the next covariate for the second model the variable that explained the greatest difference (i.e., reduced most the difference between groups) in performance between participants with and without diabetes, and that still remained statistically significant (P 0.10) after adjusting for other covariates already in the model. Once a variable had been selected, it stayed in the model. This selection process continued until no variable considered for addition improved the model.

We also assessed the differences in lower extremity functioning among PAD patients with different diabetes severity using analysis of covariance while adjusting for age, sex, race, and BMI. All analyses were conducted using SAS Statistical Software (SAS Institute Inc, Cary, NC).

	RESULTS

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS References

 
Study participant characteristics
PAD patients with diabetes were younger than those without diabetes and had a higher mean BMI, a worse neuropathy score, a higher prevalence of hypertension, and a greater number of comorbidities (predominantly cardiovascular) (Table 1). Although the mean ABI was similar between the two groups, exertional leg pain symptoms were different. PAD patients with diabetes were less likely to report intermittent claudication than those without diabetes and more likely to report leg pain on exertion and rest.

View this table: [in this window] [in a new window]   Table 1— Age-adjusted* characteristics of men and women aged 55 years with PAD according to the presence or absence of diabetes

View this table: [in this window] [in a new window]   Table 2— Age-adjusted lower extremity functioning among men and women aged 55 years with PAD according to the presence or absence of diabetes

View this table: [in this window] [in a new window]   Table 3— Adjusted association between lower leg functioning and diabetes severity among men and women aged 55 years with PAD

View this table: [in this window] [in a new window]   Table 4— Stepwise multiple linear analyses for differences in lower extremity functional measures among men and women aged 55 years with PAD according to the presence or absence of diabetes*

	CONCLUSIONS

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS References

Although most of the differences in lower extremity functioning were associated with diabetes-related factors (neuropathy and leg pain symptoms) and cardiovascular disease, even after adjusting for these and other confounders, we were not able to account for all of the differences observed between PAD participants with and without diabetes in regard to fastest-pace 4-m walking velocity and SPS. There are several potential explanations for our results. First, our neuropathy score is only a crude measure of sensory neuropathy and does not assess propioception or autonomic dysfunction, both of which may be adversely affected by diabetes and could negatively impact on lower extremity functioning. A more thorough and comprehensive investigation of diabetic neuropathy would include measurement of sensory and motor nerve conduction velocity, vibration perception threshold, warmth and cold perception threshold, and autonomic testing. Second, it is possible that medial arterial calcinosis, which is more common in people with diabetes (26,27), may have led to falsely elevated ABIs in the participants with diabetes, thereby underestimating the severity of PAD in the group with diabetes. Such an underestimation could explain the residual differences in the fastest-pace 4-m walking velocity and SPS after adjusting for ABI.

In contrast to the differences observed in measures of balance, leg strength, walking endurance, and walking speed, both self-reported and accelerometer-measured physical activities were similar between participants with and without diabetes. The reasons for this are unclear. It is possible that diabetes-related neuropathy, which accounts for much of the difference between participants with and without diabetes in the other measures, does not have a significant adverse effect on physical activity. Alternatively, it is possible that differences in physical activity levels between PAD patients with and without diabetes do exist, but that the physical activity measures used were not sensitive enough to detect these differences.

Among patients with coronary artery disease, patients with diabetes are less likely than patients without diabetes to have typical angina (28). Our findings suggest that there is a similar phenomenon in PAD patients with diabetes. Compared with PAD patients without diabetes, PAD patients with diabetes were less likely to have classical intermittent claudication but more likely to have leg pain with exertion and rest. The presence of diabetes-related neuropathy may explain the majority of the differences in leg pain symptoms between patients with and without diabetes. Altered foot architecture, common in patients with diabetes but not measured in this study, may also have contributed to the higher prevalence of leg pain on exertion and rest observed in PAD patients with diabetes.

There are several limitations to this study. First, we excluded those PAD patients from our noninvasive vascular laboratory with ABIs >0.90, a finding suggestive of calcified, noncompressible vessels that is more common in patients with diabetes than patients without diabetes (26,27). Our findings, therefore, cannot be generalized to PAD patients with diabetes who have noncompressible vessels. Second, because medial calcinosis in patients with diabetes is associated with neuropathy (29,30) to the extent that neuropathy affects lower extremity function, exclusion of PAD patients with diabetes and noncompressible vessels may have underestimated the differences in lower extremity function between PAD patients with and without diabetes. Third, despite our rigorous method of diabetes ascertainment, it is possible that our study population of PAD patients without diabetes included some subjects with undiagnosed diabetes, which might have reduced the observed differences between participants with and without diabetes. However, we believe the number of undiagnosed cases of diabetes was very small because once a patient is diagnosed with PAD, he/she is generally monitored regularly for diabetes. Fourth, we did not have information on duration of diabetes or glucose control, which may have been better measures of diabetes severity than the methods used. Although we did not have information on the type of diabetes, given the mean age of the patients with diabetes (69 years) and the small proportion of patients using insulin in the diabetic group, we estimate that the majority had type 2 diabetes.

Previous studies have shown high rates of foot ulcers and lower extremity amputations in PAD patients with diabetes as well as faster rates of PAD progression in patients with diabetes compared with patients without diabetes (3,4,31). Thus, diabetes is known to be associated with more severe forms of clinically apparent PAD. This report extends the spectrum of diabetes-related complications to include lower extremity dysfunction in PAD patients. The excess disability associated with diabetes in PAD patients is consistent with what has been found in the general population (3,5,6). Our results also give further support for aggressive lifestyle modification for diabetes prevention in those with PAD at risk for developing diabetes. Patients with PAD without established diabetes should be aggressively monitored for the development of diabetes; if they do have diabetes, they should be evaluated for the presence of associated comorbidities that could contribute to disability. Based on our data, potential interventions to improve lower extremity functioning in PAD patients with diabetes might include the development of effective treatments for leg pain on exertion and rest, prevention and treatment of neuropathy, and prevention of cardiovascular disease. Given the association between poorer lower extremity function and future disability, mobility loss, and nursing home placement (7,8), these findings are likely to have important prognostic implications for PAD patients with diabetes.

	Acknowledgments

 
Supported by grant no. R01-58099 from the National Heart Lung and Blood Institute and by grant no. RR-00048 from the National Center for Research Resources, National Institutes of Health. M.M.M. was the recipient of an Established Investigator Award from the American Heart Association and was a Robert Wood Johnson Generalist Physician Faculty Scholar.

	Footnotes

 
Address correspondence and reprint requests to Dr. Nancy C. Dolan, Northwestern University Medical School, 675 N. St. Clair, Suite 18-200, Chicago, IL 60611. E-mail: ndo428{at}northwestern.edu.

Received for publication 14 May 2001 and accepted in revised form 21 September 2001.

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

	References

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS References

 

1. Marubito JM, D’Agostino RB, Silbershatz H, Wilson WF. Intermittent claudication: a risk profile from the Framingham Heart Study. Circulation 96:44–49, 1997[Abstract/Free Full Text]
   
2. Nathan DM: Long-term complications of diabetes mellitus. N Engl J Med 328:1676–1685, 1993[Free Full Text]
   
3. National Diabetes Data Group (Eds.): Diabetes in America. 2nd ed. Bethesda, MD, National Institutes of Health (publ. no. NIH 95-1468)
   
4. Graves EJ: National Center for Health Statistics: National Hospital Discharge Survey: Annual Summary, 1990. Hyattsville, MD, National Center for Health Statistics, 1992 (Vital and Health Statistics Ser. 13, no. 112)
   
5. Gregg EW, Beckles GL, Williamson DF, Leveille SG, Langlois JA, Engelgau MM, Narayan KM: Diabetes and physical disability among older U.S. adults. Diabetes Care 23:1272–1277, 2000[Abstract/Free Full Text]
   
6. Guccione AA, Felson DT, Andersen JJ, Anthony JM, Zhang Y, Wilson PW, Kelly-Hayes M, Wolf PA, Kreger BE, Kannel WB: The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health 84:351–358, 1994[Abstract/Free Full Text]
   
7. Guralnik JM, Ferrucci L, Simonsick E, Salive ME, Wallace RB: Lower extremity function in persons over 70 years as a predictor of subsequent disability. N Engl J Med 332:556–561, 1995[Abstract/Free Full Text]
   
8. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB: A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 49:M85–M94, 1994[Medline]
   
9. McDermott MM, Criqui MH, Liu K, Guralnik JM, Greenland P, Martin GJ, Pearce W: Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease. J Vasc Surg 32:1164–1171, 2000[Medline]
   
10. Criqui MH, Denenberg JO, Bird CE, Fronek A, Klauber MR, Langer RD: The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med 1:65–71, 1996[Medline]
    
11. Guralnik JM, Fried LP, Simonsick EM, Kasper JD, Lafferty ME (Eds.): The Women’s Health and Aging Study: Health and Social Characteristics of Older Women With Disability. Bethesda, MD, National Institute on Aging, 1995 (NIH publ. no. 95-4009)
    
12. Ettinger WH, Fried LP, Harris T, Shemanski L, Schulz R, Robbins J: Self-reported causes of physical disability in older people: the Cardiovascular Health Study. J Am Geriatr Soc 42:1035–1044, 1994[Medline]
    
13. Fried LP, Bandeen-Roche K, Kasper JD, Guralnik JM: Association of comorbidity with disability in older women: the Women’s Health and Aging Study. J Clin Epidemiol 52:27–37,1999
    
14. Lyness JM, Noel TK, Cox C, King DA, Conwell Y, Caine ED: Screening for depression in elderly primary care patients. Arch Intern Med 157:449–454, 1997[Abstract]
    
15. Birke JA, Sims DS: Plantar sensory threshold in the ulcerative foot. Lepr Rev 57:261–267, 1986[Medline]
    
16. Olmos PR, Cataland S, O’Dorision TM, Casey CA, Smead WL, Simon SR: The Semmes-Weinstein monofilament as a potential predictor of foot ulceration in patients with noninsulin-dependent diabetes. Am J Med Sci 309:76–82, 1995[Medline]
    
17. Montgomery PS, Gardner AW: The clinical utility of a six-minute walk test in peripheral arterial occlusive disease patients. J Am Geriatr Soc 46:706–711, 1998[Medline]
    
18. Gardner AW, Womack CJ, Sieminski DJ, Montgomery PS, Killewich LA, Fonong T: Relationship between free-living daily physical activity and ambulatory measures in older claudicants. Angiology 49:327–337, 1998
    
19. Richardson MT, Leon AS, Jacobs DR, Ainsworth BE, Serfass R: Ability of the Caltrac accelerometer to assess daily physical activity levels. J Cardiopulm Rehabil 15:107–113, 1995[Medline]
    
20. McDermott MM, Liu K, O’Brien E, Guralnik JM, Criqui MH, Martin GJ, Greenland P: Measuring physical activity in peripheral arterial disease: a comparison of two physical activity questionnaires with an accelerometer. Angiology 51:91–100, 2000
    
21. Hiatt WR, Hirsh AT, Regensteiner JG, Brass EP: Clinical trials for claudication: assessment of exercise performance, functional status, and clinical endpoints. Circulation 3:614–621, 1995
    
22. Regensteiner JG, Steiner JF, Panzer RJ, Hiatt WR: Evaluation of walking impairment by questionnaire in patients with peripheral artery disease. J Vasc Med and Biol 2:142–152, 1990
    
23. Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV, Studenski S, Berkman LF, Wallace RB: Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with short physical performance battery. J Gerontol A Biol Sci Med Sci 55:M221–M231, 2000
    
24. McDermott MM, Liu K, Guralnik JM, Mehta S, Criqui MH, Martin GJ, Greenland P: The ankle brachial index independently predicts walking velocity and walking endurance in peripheral artery disease. Journ Am Geriatr Soc 46: 1355–1362, 1998
    
25. McDermott MM, Mehta S, Liu K, Guralnik JM, Martin GJ, Criqui MH, Greenland P: Leg symptoms and the ankle brachial index independently predict patient reported walking ability in peripheral arterial disease in patients without limb threatening ischemia. J Gen Intern Med 14:173–181, 1999[Medline]
    
26. Akbari CM, LoGerfo FW: Diabetes and peripheral artery disease. J of Vasc Surg 30:373–383, 1999
    
27. Quigley FG, Faris IB, Duncan HJ: A comparison of Doppler ankle pressures and skin perfusion pressure in subjects with and without diabetes. Clin Physiol 11:21–25, 1991[Medline]
    
28. Langer A, Freeman MR, Josse RG, Steiner G, Armstrong PW: Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiology 67:1073–1078, 1991[Medline]
    
29. Psyrogiannis A, Kyriazopoulou V, Vagenakis AG: Medial arterial calcification is frequently found in patients with microalbuminuria. Angiology 50:971–975, 1999
    
30. Edmonds ME, Morrison N, Laws JW, Watkins PJ: Medial arterial calcification and diabetic neuropathy. Br Med J (Clin Res Ed) 284:928–930, 1982
    
31. Bird CE, Criqui MH, Fronek A, Denenberg JO, Klauber MR, Langer RD: Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing. Vasc Med 4:15–21, 1999[Abstract/Free Full Text]
    

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				C. M. Findley, R. G. Mitchell, B. D. Duscha, B. H. Annex, and C. D. Kontos Plasma Levels of Soluble Tie2 and Vascular Endothelial Growth Factor Distinguish Critical Limb Ischemia From Intermittent Claudication in Patients With Peripheral Arterial Disease J. Am. Coll. Cardiol., July 29, 2008; 52(5): 387 - 393. [Abstract] [Full Text] [PDF]

				L. M. Steffen, D. A. Duprez, J. L. Boucher, A. G. Ershow, and A. T. Hirsch Management of Peripheral Arterial Disease Diabetes Spectr, July 1, 2008; 21(3): 171 - 177. [Abstract] [Full Text] [PDF]

				J. R. Lindner, L. Womack, E. J. Barrett, J. Weltman, W. Price, N. L. Harthun, S. Kaul, and J. T. Patrie Limb Stress-Rest Perfusion Imaging With Contrast Ultrasound for the Assessment of Peripheral Arterial Disease Severity J. Am. Coll. Cardiol. Img., May 1, 2008; 1(3): 343 - 350. [Abstract] [Full Text] [PDF]

				R. G. Mitchell, B. D. Duscha, J. L. Robbins, S. I. Redfern, J. Chung, D. R. Bensimhon, W. E. Kraus, W. R. Hiatt, J. G. Regensteiner, and B. H. Annex Increased levels of apoptosis in gastrocnemius skeletal muscle in patients with peripheral arterial disease Vascular Medicine, November 1, 2007; 12(4): 285 - 290. [Abstract] [PDF]

				C. Christodoulou, S. Sangle, and D. P. D'Cruz Vasculopathy and arterial stenotic lesions in the antiphospholipid syndrome Rheumatology, June 1, 2007; 46(6): 907 - 910. [Abstract] [Full Text] [PDF]

				T. M Quai, S. G Brauer, and J. C Nitz Somatosensation, circulation and stance balance in elderly dysvascular transtibial amputees Clinical Rehabilitation, June 1, 2005; 19(6): 668 - 676. [Abstract] [PDF]

				R. K Oka, E. Umoh, A. Szuba, J. C Giacomini, and J. P Cooke Suboptimal intensity of risk factor modification in PAD Vascular Medicine, May 1, 2005; 10(2): 91 - 96. [Abstract] [PDF]

				American Diabetes Association Peripheral Arterial Disease in People with Diabetes J Am Podiatr Med Assoc, May 1, 2005; 95(3): 309 - 319. [Full Text] [PDF]

				E. W Gregg and C. J Caspersen Review: Physical disability and the cumulative impact of diabetes in older adults The British Journal of Diabetes & Vascular Disease, January 1, 2005; 5(1): 13 - 17. [Abstract] [PDF]

				American Diabetes Association Peripheral Arterial Disease in People With Diabetes Clin. Diabetes, October 1, 2004; 22(4): 181 - 189. [Full Text] [PDF]

				Peripheral Arterial Disease in People With Diabetes Diabetes Care, December 1, 2003; 26(12): 3333 - 3341. [Full Text] [PDF]

				P. S. Mehler, J. R. Coll, R. Estacio, A. Esler, R. W. Schrier, and W. R. Hiatt Intensive Blood Pressure Control Reduces the Risk of Cardiovascular Events in Patients With Peripheral Arterial Disease and Type 2 Diabetes Circulation, February 11, 2003; 107(5): 753 - 756. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dolan, N. C. Articles by McDermott, M. M. Search for Related Content PubMed PubMed Citation Articles by Dolan, N. C. Articles by McDermott, M. M. Social Bookmarking                What's this?